Market Rank #22 · Evidence Tier A

India
Neuroscience Intelligence

India neuroscience intelligence: 82 indexed trials, 226 institutions, research score 38.48.

⚗
82Indexed trials
↗
18Recruiting
⌂
226Research institutions
◎
38.5Research score

Evidence profile

55Sponsors
20Disease areas
0Institution works
0Institution citations

Evidence signals

Research score 38.5 · Data confidence 100.00 · Evidence 38.5

Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.

Leading disease areas

epilepsy17trials
parkinsons11trials
other_neurology6trials
depression5trials
autism5trials
schizophrenia5trials
alzheimers5trials
pain_neuropathy5trials
stroke4trials
migraine_headache3trials

Leading indexed sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.9trials
All India Institute of Medical Sciences4trials
Newron Pharmaceuticals SPA4trials
GlaxoSmithKline3trials
Eli Lilly and Company3trials
Boehringer Ingelheim2trials
Neurovalens Ltd.2trials
Hoffmann-La Roche2trials
All India Institute of Medical Sciences, Bhubaneswar2trials
Bristol-Myers Squibb2trials